Daniela Kandioler
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal Cancer (NCT00525200) | Daniela Kandioler | 2007-06-01 |
Track Daniela Kandioler automatically
Every clearance here is in the API, with alerts when new ones post.